OBI Pharma Inc Sustainability Reports
OBI Pharma, Inc. is a clinical-stage oncology company dedicated to developing novel cancer therapeutic agents. The company specializes in antibody-drug conjugates (ADCs) and target therapies for cancer treatment with significant unmet medical needs.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG003PBPW94
18 reports from 2016 to 2025
